2012 | 2011 | 2010 | 2009 |
Myc family protiens are responsible for many critical steps in cell growth, proliferation and apoptosis. Myc, and more specifically c-myc is degregulated in many, if not all cancers, making it a useful target for therapy and future research. Ideal cancer drugs should target a function that is essential for tumor growth and survival, but that also doesn’t damage healthy tissues. A common pitfall of current treatments is the eventual resistance to the drug given, and the regeneration of a stronger, resistant tumor. Myc is found to function in aiding the expression of many different genes that together help promote somatic cell proliferation. It has been shown that myc inhibition using a dominant negative Myc mutant called Omomyc can greatly regress tumors with only slight harmful yet reversible effects on healthy tissue. This study shows that if omomyc is given in low doses in regular intervals over a prolonged period of time, it can greatly reduce the adverse effects of the treatment as well as has shown to indefinitely prevent new tumors from forming.
This suggests that Myc inhibition in this fashion, does not create mutant clones that cause resistance. This is even true in the most aggressive p53 deficient cancers. In a normal situation (non-cancer) when c-Myc is overexpressed p53 is induced to let the cell know that a crisis has occurred and starts the journey to apoptosis. In this way p53 commonly regulates c-myc. When p53 is not working correctly, it does not respond to c-myc overexpression and a decreased apoptotic response is observed.
In order to function as an agent in proliferation, as well as oncogenetic activities c-myc dimerizes with Max. Myc inhibition is achieved by blocking this interaction with Omomyc. Myc function is not replaced by any other pathway or mechanism once it is inhibited, making a very promising target for treatment. The actual mechanism for how omomyc promotes cancer cell death is still not well understood, but is a possible plug for future research.
Links related to the paper:
Omomyc, a potential Myc Dominant negative, enhances myc-induced Apoptosis
Dissecting Myc inhibition as a cancer therapy
Adenovirus-mediated Cre deletion as an effective way to study gene deletion
The repair and regrowth of neurons damaged by injury, disease or surgery is a primary goal of regenerative medicine.
Improvements in laser technology now allow individual axons to be cut and analyzed for regrowth in vivo.
In the present study, Pinan-Luccare et al. found that the core apoptotic proteins, CED-3 and CED-4, promote the
regeneration of severed neurons in C. elegans. Mutants lacking ced-3 displayed impaired regenerative outgrowth and
delayed reconnection of the dissociated ends. CED-4, the activator of CED-3, was also found to be necessary for the
initiation of the regrowth of damaged neurons. However the other regulators of apoptosis, CED-9 and CED-13, were not
required for regrowth.
CED-3 caspase was found to function in a calreticulin, calcium-dependent pathway that requires calcium signaling and
functional calreticulin gene, crt-1. Thus the core apoptotic effector proteins function in a novel pathway that
promotes neuronal regeneration. The results draw into question the use of anti-caspase therapy to limit nerve-loss
following nerve injury.
Links related to the paper:
Cell Death Review (in C. elegans)
Mechanistic insights into CED-4-mediated activation of CED-3
The C. elegans cell death gene ced-3 encodes a
protein similar to mammalian interleukin-1β-converting enzyme - C. elegans CED-3 Background
Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced
Pancreatic cancer has a 5-year survival rate of <5%, due to the fact that symptoms do not present themselves until advanced
stages and the cancer spreads rapidly. Because of it’s poor prognosis, W Sheng et al aims to investigate the relationship
between the expression of Gli1, MDM2, and p53 in pancreatic cancer, hoping to further investigate their involvement in the
aggressive behaviors of pancreatic cancer.
Previous studies have shown that all 3 play a part in the initiation and progression of cancers. Over expression of Gli1
(a transcription factor), activated by the Sonic hedgehog (Shh) signaling pathway, can result in tumor formation and a
mutation in the P53 tumor suppressor gene results in reduced apoptosis and excessive cell proliferation. Sonic hedgehog
is also known to induce MDM2, which is linked to p53 in an autoregulatory negative feedback, where MDM2 is the product of
p53 and MDM2 in return inhibits p53.
After performing various knockdown tests of Gli1, MDM2, and p53 using siRNAs, immunohistochemistry assays, immunoblot assays,
and PCR on both mutated p53 cells and normal p53 cells, Sheng et al found that patients who have Gli1 expression only or had
expression of both Gli1 and MDM2 had a lower survival rate than patients who have negative expression. Sheng et al also
observed that mutant p53, and overexpression of both Gli1 and MDM2 contributes to the advancement of pancreatic cancer.
Although they found a positive relationship between Gli1 and MDM2, their effect on p53 was dependent on whether p53 was
mutant or wild type.
Links related to the paper:
Hedgehog signalling in cancer formation and maintenance
Wnt signaling as we have learned in class is widely utilized in many cell signaling pathways mainly resulting in transcription
for cell proliferation. When parts of this pathway become mutated, a common result is the formation of cancer due to extra
signals for proliferation.
In this study, the "destruction complex" was under scrutiny, specifically the tumor suppressor adenomatous polyposis coli (APC)
component. Other components are Axin, GSK3, and CK1 with Axin interacting with Disheveled and GSK3 and CK1 seeming to be
involved in phosphorylation of APC and β-catenin. Specific binding sites displaying 15 amino acid repeats (15Rs) and
20 amino acid repeats (20Rs) were analyzed and mutated to observe their effect on β-catenin accumulation, restoration to
wild type levels, or no effect at all. To analyze APC, Drosophila APC genes APC1 and APC2 were hypothesized for use because
vertebrates contained far too many APC's and APC binding sites to manipulate, however only APC2 was investigated. Mutants
created were: APC2Δ20R2 meaning only the second amino acid repeat was knocked out, APC2Δ20R1, R3-R5 meaning this
mutant only had the second amino acid repeat described above, APC215Rs, 20R1, R4,R5 meaning all the 15Rs were knocked out and
only the 20R2&3 remained.
From the results it seemed the 20R2, which did not have the ability to bind β-catenin, still rescued any mutation and was
suggested to be vital to APC functionality. The 20Rs had more positive rescue on β-catenin levels than 15Rs. Even levels
of β-catenin were reduced when all sites from APC were eliminated suggesting actual binding to APC was not necessary for
β-catenin destruction and even at times it seemed β-catenin was being retained in the cytoplasm, not letting it enter
the nucleus.
Overall goal of this research was not directly stated in the paper but it would seem advantageous to understand the destruction
complex in order to possibly control levels of β-catenin that is promoting cancer. Understanding the key binding sites and
proteins may help in new drug treatments toward stopping tumorigenesis.
Links related to the paper:
B-catenin/armadillo - Various names for B-catenin
Understanding and identifying amino acid repeats
Mechanism of Phosphorylation-Dependent Binding of APC to β-Catenin and Its Role in β-Catenin Degradation
- more on phosphorylation of APC
Apoptosis is a key mechanisms to maintaining homeostasis and helps dismiss damaged or unwanted cells. In addition to being a
proto-oncogene, c-Myc also acts as a tumor suppressor gene, and resides within the Myc family of short-lived nuclear
phosphoproteins. These proteins are multi-functional, and are associated with cell growth, cell cycle progression,
apoptosis, and cellular differentiation via transcriptional modulation. Specifically, c-Myc encodes for a major chunk of
the basic helix-loop-helix leucine zipper family of transcription factors, and is nearly only active when a specific protein
that bind upstream of the c-Myc promoter; appropriately named 'Far Upstream Element-Binding Proteins' (FBP). Low levels of
c-Myc mRNA and protein are found in normal proliferating cells, and slight deviations from this optimal concentration lead
to either cell proliferation or apoptosis. This study looks at when and where this transition from oncogenic to tumor suppressant occurs.
Previous studies have shown this proto-oncogene to also play a role in the induction of apoptosis by means of Bax
oligomerization and the 'caspase feedback amplification loop' (Cao et al, 2008). This feedback amplification loop is
essentially the point at which apoptotic events are irreversible. The activation of initiator caspases lead to a
self-promoting mechanism that leads to the degredation of cytochrome c in the mitochondria, as well as other interactions
involving their target substrates, such as FBP-1 (Chen et al, 2005). I addition, this interaction of FBP-1 with caspases
appear to be the final nail in the coffin for the cells fate (pun intended).
The present study assists us on the understanding of the sequence of events leading to apoptosis by means of caspase
monitoring. The results show FBP-1 as a candidate substrate for the effector caspase-7, and thus, when activated by
apoptotic stimuli, caspase-7 will cleave FBP-1 and lead to the down regulation of c-myc. For that reason, the downregulation
of the FBP-1 may function as the 'switch off' mechanism for the caspase feedback amplification loop, as well as c-Myc's
proliferation signalling function.
Links related to the paper:
Apoptosis: a criticial of homeostasis - a short overview of apoptosis and its functions
Cell cycle: on target with Myc
Myc and the cell cycle - abstract of another paper going into detail about Myc's role in the cell cycle
Distinct stages of cytochrome c release from mitochondria - A helpful article on the caspase feedback amplification loop
Some antibiotics acting as polyether ionophores have been used in selective cancer stem cell inhibition, but have also
been found to have some anticancer effects. With increasing amount of studies done on Wnt/β-catenin signaling
pathways and the connection to cancer activation, this study aims to characterize salinomycin as an inhibitor of the
pathway by means of ionic changes that interfere with LRP6 phosphorylation.
LRP6, or lipoprotein receptor related protein 6, is a necessary co-receptor in the Wnt signaling pathway that interacts
with Dickkopf-1 (DKK-1) for activation. The experiments done by Lu et al. have found salinomycin as an antagonist
promoting the degredation of β-catenin and the downregulation of Wnt target genes contributing to cancer. In this
study, chronic lymphocytic leukemia (CLL) is examined due to its prevalence in the Western world, and the actions of
salinomycin have been directed toward these cells. Even at subnanomolar concentrations, salinomycin was found to be
toxic selectively to primary CLL cells, but still suppressed Wnt-induced LRP6 phosphorylation.
There is so much potential in targeting LRP6 for cancer cell therapy through the use of drugs that alter phosphorylation
and stability. Studying the mechanism of ion exchange and its effect on the canonical Wnt pathway may help in the
development of drugs and antibiotics that have potential therapeutic use in cancer.
Links related to the paper:
Mechanism for co-receptors in Wnt signaling
Developing drugs with potential to inhibit cancer stem cells
Many anticancer drugs rely on the presence of p53 wild-type in tumorous cells, such as Doxorubicin. The expected result for these drugs is p53-dependent apoptosis or senescence. If p53 is not present or expresses p53 (mutant) there is increased resistance in chemotherapy. There is high frequency of these mutations in human tumor cells thus, research concerning p53 is important.
Breast cancer susceptibility gene 1 (BRCA1) is a genetic predisposition for breast, ovarian and in this case prostate cancer (PCa). Previously the DeLuca group determined that GADD153, promoter protein in the G2/M DNA damage signaling pathway, increases apoptosis and cell cycle arrest in BRCA1 over-expressing cells; inducing doxorubicin sensitivity.
In this experiment the DeLuca group investigates the effect of p53 over GADD153 regulation by BRCA1 during the DNA damage response—specifically in PCa LNCaP cells that express p53 wild-type. What was found is BRCA1 targets GADD153 promoter and during DNA damage response increases transcription. It was also shown that p53 abolishes GADD153 induction from DNA damage. The explanation for this may be due to BRCA1 being repressed by p53. BRCA1 protein binds and regulates GADD153 promoter, independently of p53 presence, but GADD153 induction from DNA damage is lost in p53 expressing cells due to p53 repression of GADD153 and BRCA1. Both BRCA1 and p53 regulate several pathways in PCa cells especially in DNA damage, EMT and Hedgehog pathway. The importance of this study shows that BRCA1 and p53 and extremely important transcription regulators in PCa.
Links related to the paper:
BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer - De Luca Previous Study (2011)
Cell Cycle G2/M DNA Damage Signaling Pathway
During normal development, many cells undergo apoptosis and it is important for these cells’ corpses to be removed from the embryo
following this programmed cell death. This regulated process involves the display of an “eat me” signal which tells neighboring
cells to consume and degrade the corpse.
Many studies involving chick and C. elegans embryos suggest that autophagy proteins may be essential for corpse clearance during
programmed cell death. Further support of this is seen in Huang et al (2013) where an increased number of apoptotic cell corpses
are detected in C. elegans embryos with mutations in autophagy genes (such as bec-1). This difference can be explained by
a delay in corpse clearance, as this paper demonstrated.
Results suggested that bec-1, and other autophagy genes, may function in both apoptotic cell corpse engulfment and degradation
during C. elegans embryonic development.
Links related to the paper:
Differential Interference Contrast Microscopy
Abl Kinase Inhibits the Engulfment of Apopotic
Cells in Caenorhabditis elegansAbl Is Able to Inhibit Cell Engulfment - A quick look at the pathways mentioned in the paper (the picture on the right).
Supplemental Content for Presentation Paper -
Supplemental figures can be downloaded (free) by clicking "supplemental" in the green box on the right
Apoptosis, programmed cell death, occurs in multicellular organisms and can be caused by extracellular or intracellular inducers.
Cells undergoing apoptosis will undergo morphological changes, which include nuclear fragmentation, bulging of the cell membrane,
cell shrinkage, chromatin condensation. Apoptosis is beneficial for maintaining cell homeostasis and for protecting surrounding cells.
Previous studies have shown that this execution of cell suicide helps to regulate the number of available cells. C. elegans
undergo apoptosis during early embryonic development, “to endure functional organ architecture and to maintain tissue homeostasis”
(Lettre and Hengartner, 2006). During C. elegans development, 131 out of 1090 somatic cells that are formed undergo apoptosis
(Sulston and Horvitz, 1977; Sulston et al, 1983). These 131 somatic are not necessary for the viability of the nematodes. It is
important to be able to be able to follow the life and death sequence of the cells and how it is able to occur. Three key genes,
which are necessary for programmed cell death in development (apoptosis), have been identified in C. elegans: ced-3, ced-4, and egl-1
(ced denotes cell death abnormal, while egl stands for EGg laying defective). Ced-3, ced-4 and egl-1 are all pro-apoptotic genes and
if a loss-of-function mutation occurs in any of these genes then the cell death of most or all the cells is sufficiently repressed.
Developmental apoptosis is also blocked by ced-9. Constitutive germ cell apoptosis (CGCA) is dependent on ced-4 and ced-3 and is
blocked by ced-9 (Schertel and Conradt). CGCA however is not dependent on egl-1.
In humans the retinoblastoma is functionally inactivated in most human solid tumors. The RB has been known to block cell proliferation
by binding proteins that will block transcription before the G1- S phase. Similarly to RB gene in humans, C. elegans have orthologs
of components of the RB tumor suppressor complex. lin-35, like RB, also has functional role in the differentiation and proliferation of
the cell. This article looked at the lin-35 as well as other genes necessary for germ cell apoptosis and how they function. These
other genes include dpl-1 DP, efl-1 E2F and efl-2 E2F. lin-35 role in apoptosis has never been studied before. This article showed
that lin-35 and dpl-1 DP, efl-1 E2F and efl-2 E2F all play a role in germ cell apoptosis, but lin-35 role was different from the other
genes. This article showed that lin-35/Rb inhibits ced-9/ Bcl-2, which would promote CGCA by blocking the anti-apoptotic gene ced-9.
Where as dpl-1, efl-2 and efl-1 induce the function of ced-4 and ced-3 downstream of ced-9. Although all of these genes function in
the normal C. elegan cells, when the DNA is damaged efl-1 does not play any role in apoptosis in these cells.
Links related to the paper:
Translocation of C. elegans CED-4 to Nuclear Membranes During Programmed Cell Death
In a normal system, pruning of axons and neuronal cell death occur naturally to help shape and improve neuronal connections.
This occurs all throughout the nervous system during development as well as after injury in adults and is implicated in
several neurodegenerative diseases, including Alzheimer's disease. Neuronal development consists of two stages, the
development stage and the regressive stage. In the development stage, neurons are generated and axons extend out to form
connections. After this, there is what is called a “regressive phase” where only a portion of the neurons made are selected
to live while the rest die by apoptosis, and the axon branches are reduced to make the connections more precise. Despite
the importance of these processes, very little is known about the mechanisms by which this occurs.
To perform this study, Nikolaev et al. used several different methods. Fluorescence in situ hybridization was used to
screen TNF receptors to analyze their involvement in neuronal development and it is from this that DR6 was chosen as a focus.
This was due in part to its high expression in dividing neurons in the spinal cord and adjacent ganglia. In order to analyze
the specifics of axon pruning, Campenot chambers were used and the axons were stained and observed with TuJ1 immunostain while
various trophic factors (TFs) and nerve growth factors (NGFs) were added or removed.
From this experiment, the researchers propose that there is a pathway for cell death and axonal degeneration that follows a
'ligand activation' model. They also suggest that it is caspase-dependent and catalyzed by the binding of a fragment of
β-amyloid precursor protein (APP), called the N terminus of APP (N-APP), to death receptor 6 (DR6). They also report
that there is a difference in the type of caspase that is involved in the death of the neuronal cell body (caspase 3) and
the pruning of the axons (caspase 6).
Links related to the paper:
Campenot chambers - See figure 3 for a nice, concise description of Campenot chambers
APP processing and the link to Alzheimer's disease
Dependence receptors are a potential target for cancer treatments and are receptors that initiate apoptosis in the absence
of their ligand. By forcing expression of these receptors in tumor cells, apoptosis can be induced. Understanding the
natural function and interactions these particular receptors have is therefore important.
Cell-adhesion molecule-related/downregulated by oncogenes (CDO) is a dependence receptor involved in canonical Sonic Hedgehog
(SHH) signaling. This specific study sought to understand CDO’s activity in branchial arch formation through in vivo experimentation.
In order to achieve this goal, electroporation was performed on half of chick neural tube to force expression of CDO in
this location. Neural tube was utilized as the experimental site because SHH is known to be expressed in the neural
tube in a dorsal-ventral concentration gradient. Monitoring of CDO expression using immunofluorescence as well as
monitoring of apoptosis through TUNEL staining showed heightened apoptosis in the dorsal region of CDO expressing neural
where SHH concentration is low. CDO thus activated apoptosis in the absence of its ligand, SHH.
This mechanism was also present in branchial arch development. SHH secreted by the ventral foregut was responsible for
the survival of facial neural crest cells. CDO caused facial neural crest cells forming in the incorrect location to
undergo apoptosis.
Links related to the paper:
Canonical SHH Signaling Pathway - See figure 6.(A)
Why Understand Dependence Receptors?
What is a Dependence Receptor?
SHH Signaling's Role in Cancer
Neural tube defects are severe birth defects caused by a failure of the neural tube to fully close, including spina bifida
and anencephaly. There are several points at which closure happens throughout development, the final being the posterior
neural pore (PNP). NTDs may have a genetic component, but only a few genes have been linked to human NTDs. However, in mice,
over 200 genes have been identified. Since the mouse is used as a model organism for humans, some of the genes causing the
defects in the mice are likely to have a homolog involved in the same process in humans. The better understanding gained
about neural tube closure in mice, the better NTDs in humans can be identified early in pregnancy.
Previous studies have shown that there is strong evidence for the non-canonical Wnt, or planar cell polarity (PCP) pathway
being involved in the process for neural tube closure (Wallingford, 2006). However, many of the molecules involved in the PCP
signaling pathway are also involved in the canonical Wnt signaling pathway (MacDonald et al, 2009). This study aims to analyze
the role of the canonical Wnt signaling pathway in neural tube closure. The hypothesis states that canonical Wnt/β-catenin
signaling is required for neural tube closure in mice through the regulation of transcription of downstream target genes,
including Pax3 and Cdx2.
Using Cre-lox conditional gene targeting, the researcher created a β-catenin conditional knockout (cKO) to analyze the
role of the canonical Wnt signaling pathway. The study showed that after 9.5 days of development, which equates to about 22
days in humans, there was defective PNP closure and elongation of the embryos, showing that β-catenin is indeed necessary
for PNP closure. In addition, the study shows that Pax3 and Cdx2 are target genes of the canonical Wnt signaling pathway,
because levels of Pax3 and Cdx2 were repressed in the β-catenin knockouts. Finally, the study showed that transgenic
activation of Pax3 cDNA can rescue the PNP closure defect, but cannot restore Cdx2 levels on its own. Therefore, the study
concluded that β-catenin is in fact necessary for caudal neural tube closure and elongation, and that it functions
through the transcription of target genes including Pax3 and Cdx2.
Links related to the paper:
Role of PCP Genes and Neural Tube Closure
More on mice used in the experiment
Even more on mice used in the experiment
And more on the mice used in the experiment
Luciferase assay and chromatin immunoprecipitation methods
More on Luciferase assay and chromatin immunoprecipitation methods
Digoxigenin-labeled antisense RNA from our book!
Cre-lox recombination in transgenic mice
Multiple studies in the past have looked at the embryonic pattering in different model organisms at the molecular level. Anterior
visceral endoderm (AVE) is found to express inhibitors of Wnt/β-catenin pathway. Posterior visceral endoderm (PVE) allows
the formation of the gastrula organizer as well as the primitive streak. This consequentially leads to definitive endoderm (DE).
A previous study showed that by deleting the β-catenin in epiblast progenitors, there is a loss of DE. This illustrates that
Wnt and β-catenin are necessary in the development of mesoderm and endoderm specification.
However, the purpose of Wnt/β-catenin signaling in detail for AVE, PVE, and DE is not yet understood. The studies done by
Engert et al discuss the function of this signal pathway by using conditional knockout protocol to see the effects of removing
β-catenin resulting from the Sox17 gene. The CKO embryos result in head and tail truncations, causing them to be embryonic lethal.
To perform the study, Engert et al floxed as well as flox deleted β-catenin alleles for Sox17-pos mice. Immunofluorescence
methods was performed using various tagging antibodies. Furthermore, tetrapod chimeras were used to observe the rescue of head/tail
truncated embryos. Embryos were stained with a β-galactosidase stain, dehydrated via ethanol series, and mounted on slides.
Engert et al discovered that SOX17 was expressed in AVE and PVE on day 6.5 of development, while it was expressed in DE at day 7.5.
More importantly, they found that the absence of β-catenin resulted in truncated versions of the neural tube and head,
indicating the there was a defect in the organizer tissues (ie. AVE and DE). This suggests that the β-catenin loss results
in non-autonomous defects resulting in head and tail truncations; β-catenin is necessary for the AVE and DE formation and
consequentially head and neural tube formation. Moreover, they found that the Wnt/βcatenin signaling in Sox17 allows for the
specification between De and mesoderm epiblast. CKO on Sox17 embryos resulted in gut defects indicating Sox17 plays a role in the
Wnt signaling of a developing mouse.
Links related to the paper:
Mouse Atlas Project - Informative visuals on mouse development.
It will help give a temporal context for the Engert et al 2013 article.
Sox17 Gene Database Information
http://www.genoway.com/services/es-cell/knockout-mouse/conditional-ko-tissue.htm
Chapter summaries of the Mouse Development Book - The related
chapters are useful. They're quick synopses of each concept. So really easy to search through and find quick tidbits on embryonic
patterning/regional specifi
Deciphering the function of canonical Wnt signals in development and disease:
conditional loss- and gain-of-function mutations of β-catenin in mice - Study discussing the loss of functional mutations
concept during mouse development
Related Function of Mouse SOX3, SOX9, and SRY HMG Domains Assayed by
Male Sex Determination - Another study about SRY, and other SOX genes done on mice
The Wnt pathway is a very important pathway involved in development of embryos. Recent studies regarding the Wnt pathway have
shown its involvement in the development of the face and oral regions. The formation of the vertebrate face is in part due to
the fusion of what are known as facial primordia, or facial buds and the Wnt pathway is involved in this process.
Not very much is known about the formation of the upper jaw so this study aimed to study whether the Wnt/β-catenin signaling
pathway was necessary for the formation of the upper jaw in chick embryos. Previous studies had shown the Lhx8, Msx1, and Msx2
genes were all involved in the proper formation of facial and head regions of mice, and so the researchers decided to use the
regulation of expression of these genes to gauge the Wnt pathway’s involvement in the formation of the upper jaw. In the previous
studies when the aformentioned genes were mutated, the animal developed malformations located in the oral region (i.e. inability
for proper fusion of the palatal shelf that lead to cleft palate). These genes are especially intriguing as they might be involved
in cleft lip and cleft palate birth defects, which is the most common craniofacial defect found in children around the world.
The researches decided to use the chick embryo as the model organism for this experiment because the chicken embryo develops
quickly and because it’s developmental conditions can be manipulated easily. The researchers also decided to use Dickkopf-1
(Dkk-1) soaked beads that were inserted to the right side of the maxillary prominence (specific region of the face) to test the
Wnt pathway’s involvement; this would hopefully cause a loss-of-function of the Lhx8, Msx1, and Msx2 genes. Dkk-1 is a secreted
protein that interacts with the LRP5/6 co-receptors; these co-receptors are what Wnt ligands also bind to when they bind to
Frizzled to intiate Wnt pathway cascade. Dkk-1’s interactions with the LRP 5/6 co-receptors inhibit the Wnt pathway by blocking
the Wnt ligangd’s ability to bind to Frizzled and the LRP 5/6 co-receptor.
From this study the researchers discovered that Dkk-1 did in fact inhibit the proper formation of the chick’s jaw area and
therefore the Wnt pathway was involved. The side of the chick’s face that was treated with a Dkk-1 soaked beads had incomplete
development of the bones in the upper jaw and facial region. Also when PCR’s were done for Lhx8, Msx1, and Msx2 in the presence
of the Dkk-1 bead, there was definitely a decrease in expression when compared to the controls (which were left to develop
normally) and the regions that were treated with Bovine Serum Albumin (which acted like the injected controls of our chick
teratogenesis lab). The researchers also discovered that the Wnt pathway only affected the pattern formation of the facial
structures at certain stages of development. The Dkk-1 bead only affected the formation of the upper jaw structures at an earlier
stage (in this experiment it only had an affect on the HH22 stage which is about 4 days old). When the Dkk-1 soaked bead was
inserted into later stage embryos the effect was either much less or there was no observable effect.
Links related to the paper:
Lrp6-mediated canonical Wnt signaling is required for lip formation and fusion
Msx homeobox gene family and craniofacial development
Secreted antagonists of the Wnt signalling pathway
- Helpful for understanding how Dkk-1 inhibits the Wnt pathway
Wnt/β-catenin Signaling in Oral Tissue Development and Disease
- Helpful review on the general topic but also explains the pathway's involvement in cleft lip defects
Breast cancer is the most prevalent invasive cancer seen in women around the world. As with any cancer, breast tissue cells
become cancerous when they divide in an uncontrolled manner, lose the ability to undergo apoptosis when necessary, and become
undifferentiated. As such, in basil-like breast cancer, the epithelial cells that comprise the basal portion of breast tissue
undergo what is called an Epithelial Mesenchymal Transition (EMT), where these cells acquire a phenotype other than the normal
epithelial phenotype (e.g. dedifferentiation). This transition to a mesenchymal, stem-like phenotype is associated with metastasis
to other tissues, provided these cells also possess the ability to seed a new tumor in distant tissues (not all metastatic cancer
cells have this ability). Wnt signaling has been found to function in several human cancers (recall the role of the Wnt signaling
pathway in liver cancer, as elucidated by Reed et al. in 2008).
Here, DiMeo et al. (2009) look at the possible role of Wnt signaling in breast cancer primary tumor formation, metastasis,
and secondary tumor formation at distant sites. They investigated this in several ways. First, they compared the levels
of β-catenin in primary tumor cells in mice breast tissue to that in secondary tumor cells (that arose from metastasis),
noting that β-catenin levels are indicative of Wnt signaling. They show that the secondary tumor cells possessed high
levels of β-catenin compared to the primary tumor cells, telling them Wnt signaling is indeed the cause of metastasis and
initiation of secondary tumor formation. Second, they discovered a genetic signature present in cells of secondary tumors:
genes known as slug and twist are highly expressed. These genes code for transcription factors (SLUG and TWIST), which cause
the cells to undergo an EMT and metastasize to distant tissues. Finally, they examined potential inhibitors of this Wnt pathway.
They discovered that Wnt inhibitor Dickkopf (DKK1) was able to inhibit this Wnt pathway by blocking the binding of LRP6 to the
Frizzled receptor, disallowing Frizzled to activate Disheveled, which allows for continuing β-catenin degradation by the
destruction complex (e.g. the Wnt signaling pathway is turned off). Another inhibitor, SFRP1, which binds to extracellular Wnt
ligands and blocks their ability to bind to the Frizzled receptor, was unable to effectively inhibit the Wnt pathway in vivo,
probably because these cancerous cells produce so much Wnt signal that SFRP1 cannot meaningfully compete with Wnt pathway activation.
The significance here is related to what we can do with this knowledge. Understanding the molecular basis of how breast cancer
metastasizes and initiates tumor formation allows us to improve detection techniques, design more efficacious treatment, and save lives.
Links related to the paper:
Breast Cancer - General Information
Epithelial-Mesenchymal Transition
Secreted Antagonists of the Wnt Signaling Pathway - Includes info on Dickkopf (DKK1)
Genes that Mediate Breast Cancer Metastasis to Lung
The Core Apoptotic Executioner Proteins CED-3 and CED-4 Promote Initiation of Neuronal Regeneration in Caenorhabditis elegans
Pinan-Lucarre B, Gabel CV, Reina CP, Hulme SE, Shevkoplyas SS, Slone RD, Xue J, Qiao Y, Weisberg S, Roodhouse K, Sun L, Whitesides GM, Samuel A, Driscoll M
2012, PloS Biology, Vol 10
Presented by Sean Vogel
The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer
Sheng W, Dong M, Zhou J, Li X, Lui Q, Dong Q, & Li F
(2013) Histopathology 64:523–535
Presented by Tram Nguyen
Testing Models of the APC Tumor Suppressor/B-Catenin Interaction Reshapes Our View of the Destruction Complex in Wnt Signaling
Yamulla RJ, Kane EG, Moody AE, Politi KA, Lock NE, Foley AVA, & Roberts DM
(2014) Genetics, Vol. 197, pg 1285-1302
Presented by Karissa Hagen
Dec. 8, 2014 Presentations
Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc oncogene
Jang M, Park BC, Kang S, Chi S-W, Cho S, Chung SJ, Lee SC, Bae K-H, Park SG
(2009) Oncogene 28: 1529-1536
Presented by Ian Richardson
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
Lu D, Choi MY, Yu J, Castro JE, Kipps TJ, Carson DA
(2011) Proceedings of the National Academy of Sciences 108:13253-13257
Presented by Rommel Pinlac
BRCA1 and p53 regulate critical prostate cancer pathways
P De Luca, CP Moiola, F Zalazar, K Gardner, ES Vazquez and A De Siervi
(2013) Prostate Cancer and Prostatic Disease Vol. 16, pp. 233-238
Presented by Michael Symons
Dec. 3, 2014 Presentations
Autophagy genes function in apoptotic cell corpse clearance during C. elegans embryonic development
Huang S, Jia K, Wang Y, Zhou Z, Levine B
(2013) Autophagy 9: 138-149
Presented by Lyn Harder
C. elegans orthologs of components of the RB tumor suppressor complex have distinct pro-apoptotic functions.
Claus Schertel and Barbara Conradt
Development 134
Presented by James Leong
APP Binds DR6 to trigger axon pruning and neuron death via distinct caspases
Anatoly Nikolaev, Todd McLaughlin, Dennis D. M. O'Leary, and Marc Tessier-Lavigne
(2009) Nature 457: 981-990
Presented by Erica Young
Sonic Hedgehog promotes the survival of neural crest cells by limiting apoptosis induced by the dependence receptor CDON during branchial arch development
Delloye-Boureois C, Rama N, Brito J, Douarin NL, Mehlen P
(2014) Biochemical and Biophysical Research Communications 452(2014): 655-660
Presented by Amanda Skinner
Nov. 24, 2014 Presentations
β-catenin regulates Pax3 and Cdx2 for caudal neural tube closure and elongation
Zhao T, Gan Q, Stokes A, Lassiter RNT, Wang Y, Chan J, Han JX, Pleasure DE, Epstein JA, Zhou CJ
(2014) Development 141(1): 148-157
Presented by Claire Kuelbs
Wnt/β-catenin signalling regulates Sox17 expression and is essential for organizer and endoderm formation in the mouse
Silvia Engert, Ingo Burtscher, W. Perry Liao, Stanimir Dulev, Gunnar Schotta and Heiko Lickert.
(2013) Development 140: 3128-3138
Presented by Daniel Chou
Inhibition of Wnt/β-catenin pathway by Dikkopf-1 affects midfacial morphogenesis in chick embryo
Kawakami M, Okuda H, Tatsumi K, Kirita T, and Wanaka A
(2013) Journal of Bioscience and Bioengineering 117: 664-669
Presented by Maria Chacon
A Novel Lung Metastasis Signature Links Wnt Signaling with Cancer Cell Self-Renewal and Epithelial-Mesenchymal Transition in Basal-like Breast Cancer
DiMeo TA, Anderson K, Phadke P, Feng C, Perou CM, Naber S, and Kuperwasser C
(2009) Cancer Research
Presented by Jesse Cottle